Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026

Same author

Oscillatory edge connectivity in pain-related regions supports machine learning identification of migraine.

The journal of headache and pain·2026

Same author

Frontal Delta Decreasing and Occipital Ictal Alpha Increasing Associated With Migraine in Preictal and Ictal Phases.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026

Same author

Unmasking the noise: aberrant cortical oscillations in visual snow syndrome.

The journal of headache and pain·2026

Same author

Neuronal Intranuclear Inclusion Disease Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report.

Acta neurologica Taiwanica·2025

Same author

Temporal stability and neural complexity in resting-state MEG predict migraine phenotypes.

The journal of headache and pain·2025

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Gabapentin for decerebrate rigidity: a case report.

Chuen-Der Kao¹, Jen-Tse Chen, Kuan-Lin Lai

¹Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan.

Clinical Drug Investigation

|December 18, 2007

Summary

This summary is machine-generated.

Gabapentin significantly improved decerebrate rigidity in a patient with a pontine hemorrhage. This suggests gabapentin may be an effective treatment for this severe neurological condition.

Related Experiment Videos

Last Updated: Jul 9, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Area of Science:

Neuroscience
Neurology
Clinical Case Study

Background:

Pontine tegmentum hemorrhage can lead to severe neurological deficits, including decerebrate rigidity (DR).
Decerebrate rigidity is characterized by abnormal extensor muscle hypertonicity, often indicating severe brainstem dysfunction.
Current treatments for DR focus on managing muscle hypertonicity, with varying degrees of success.

Observation:

A 48-year-old female patient experienced sudden loss of consciousness due to a right rostral pontine tegmentum hemorrhage.
The patient presented with decerebrate rigidity and regained full consciousness after 5 days.
Despite treatment with other antiepileptic drugs, gabapentin (1200 mg/day) led to significant improvement in DR.

Findings:

Gabapentin administration resulted in marked improvement of decerebrate rigidity.
Preserved consciousness and motor-evoked potentials suggested extrapyramidal tract derangement with intact pyramidal tracts.
The study explores the potential mechanisms of gabapentin's efficacy in treating decerebrate rigidity.

Implications:

Gabapentin may represent a novel therapeutic option for managing decerebrate rigidity.
Understanding gabapentin's mechanism in DR could lead to targeted neuroprotective strategies.
This case highlights the importance of evaluating gabapentin for specific neurological conditions involving brainstem injury.